These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia. Lemancewicz D, Dziecioł J, Kłoczko J, Piszcz J. Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148 [Abstract] [Full Text] [Related]
9. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence. Prescrire Int; 2005 Feb 12; 14(75):3-5. PubMed ID: 15747447 [Abstract] [Full Text] [Related]
10. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia. Lam CC, Ma ES, Kwong YL. Am J Hematol; 2005 Aug 12; 79(4):288-90. PubMed ID: 16044456 [Abstract] [Full Text] [Related]
11. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. Smolej L, Kasparová P. APMIS; 2008 Dec 12; 116(12):1058-62. PubMed ID: 19133008 [Abstract] [Full Text] [Related]